Search - tctmd.com

Displaying 21 - 40 of 45

Sort: Relevancy | Date

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

Presentation TCT 2023

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Presenter: David Tryon

October 25, 2023

Presentation TCT 2022

COSIRA-II – Trial Design and Status Update

Presenter: Gregg Stone

September 18, 2022

Presentation TCT 2022

Reducer Data and a “No Option Patient”

Presenter: Natalia Pinilla

September 18, 2022

Presentation TCT 2022

Reducer Device Overview and Mechanism of Action

Presenter: Allen Jeremias

September 18, 2022

Presentation TCT 2022

Angina - the Scope of the Problem

Presenter: Timothy Henry

September 18, 2022

Presentation TCT 2021

TCT 696: Coronary sinus reducer transfemoral extraction after intraprocedural device migration to pulmonary artery

Presenter: Alfonso Jurado

November 04, 2021

$Slovenia Presents: Multimodal Treatment of Refractory Angina Pectors With CFR (Coronary Flow Reducer) Implantation$

Presentation TCT 2019

Slovenia Presents: Multimodal Treatment of Refractory Angina Pectors With CFR (Coronary Flow Reducer) Implantation

Presenter: Matjaz Bunc

September 27, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

$Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina$

Presentation

Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina

April 16, 2018

$Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina$

News Daily News

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

Todd Neale

April 16, 2018

$First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease$

Presentation TCT 2017

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Presenter: Daniel Burkhoff, Samir R. Kapadia, Alaide Chieffo

November 01, 2017

$The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina$

Presentation JIM 2017

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

Presenter: Francesco Giannini

February 10, 2017

Presentation TCT 2016

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gregg W. Stone

October 31, 2016

Advertisement

What’s Going to Be Hot at ACC 2024

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

COSIRA-II – Trial Design and Status Update

Reducer Data and a “No Option Patient”

Reducer Device Overview and Mechanism of Action

Angina - the Scope of the Problem

TCT 696: Coronary sinus reducer transfemoral extraction after intraprocedural device migration to pulmonary artery

Slovenia Presents: Multimodal Treatment of Refractory Angina Pectors With CFR (Coronary Flow Reducer) Implantation

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

TCTMD’s Top 10 Most Popular Stories for April 2018

Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content